1789 related articles for article (PubMed ID: 29669176)
21. Intravitreal steroids versus observation for macular edema secondary to central retinal vein occlusion.
Gewaily D; Muthuswamy K; Greenberg PB
Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD007324. PubMed ID: 26352007
[TBL] [Abstract][Full Text] [Related]
22. Anti-vascular endothelial growth factor for proliferative diabetic retinopathy.
Martinez-Zapata MJ; Salvador I; Martí-Carvajal AJ; Pijoan JI; Cordero JA; Ponomarev D; Kernohan A; Solà I; Virgili G
Cochrane Database Syst Rev; 2023 Mar; 3(3):CD008721. PubMed ID: 36939655
[TBL] [Abstract][Full Text] [Related]
23. Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for diabetic macular oedema.
Parravano M; Menchini F; Virgili G
Cochrane Database Syst Rev; 2009 Oct; (4):CD007419. PubMed ID: 19821414
[TBL] [Abstract][Full Text] [Related]
24. Non-steroidal anti-inflammatory drugs versus corticosteroids for controlling inflammation after uncomplicated cataract surgery.
Juthani VV; Clearfield E; Chuck RS
Cochrane Database Syst Rev; 2017 Jul; 7(7):CD010516. PubMed ID: 28670710
[TBL] [Abstract][Full Text] [Related]
25. Adjunctive steroid therapy versus antibiotics alone for acute endophthalmitis after intraocular procedure.
Kim CH; Chen MF; Coleman AL
Cochrane Database Syst Rev; 2017 Feb; 2(2):CD012131. PubMed ID: 28225198
[TBL] [Abstract][Full Text] [Related]
26. Prophylactic non-steroidal anti-inflammatory drugs for the prevention of macular oedema after cataract surgery.
Lim BX; Lim CH; Lim DK; Evans JR; Bunce C; Wormald R
Cochrane Database Syst Rev; 2016 Nov; 11(11):CD006683. PubMed ID: 27801522
[TBL] [Abstract][Full Text] [Related]
27. Anti-vascular endothelial growth factor for neovascular glaucoma.
Rittiphairoj T; Roberti G; Michelessi M
Cochrane Database Syst Rev; 2023 Apr; 4(4):CD007920. PubMed ID: 37010901
[TBL] [Abstract][Full Text] [Related]
28. Anti-vascular endothelial growth factor for control of wound healing in glaucoma surgery.
Cheng JW; Cheng SW; Wei RL; Lu GC
Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD009782. PubMed ID: 26769010
[TBL] [Abstract][Full Text] [Related]
29. Anti-vascular endothelial growth factors in combination with vitrectomy for complications of proliferative diabetic retinopathy.
Dervenis P; Dervenis N; Smith JM; Steel DH
Cochrane Database Syst Rev; 2023 May; 5(5):CD008214. PubMed ID: 37260074
[TBL] [Abstract][Full Text] [Related]
30. Radiotherapy for neovascular age-related macular degeneration.
Evans JR; Igwe C; Jackson TL; Chong V
Cochrane Database Syst Rev; 2020 Aug; 8(8):CD004004. PubMed ID: 32844399
[TBL] [Abstract][Full Text] [Related]
31. Adjunctive steroid therapy versus antibiotics alone for acute endophthalmitis after intraocular procedure.
Emami S; Kitayama K; Coleman AL
Cochrane Database Syst Rev; 2022 Jun; 6(6):CD012131. PubMed ID: 35665485
[TBL] [Abstract][Full Text] [Related]
32. Laser-assisted cataract surgery versus standard ultrasound phacoemulsification cataract surgery.
Narayan A; Evans JR; O'Brart D; Bunce C; Gore DM; Day AC
Cochrane Database Syst Rev; 2023 Jun; 6(6):CD010735. PubMed ID: 37369549
[TBL] [Abstract][Full Text] [Related]
33. Standard threshold laser versus subthreshold micropulse laser for adults with diabetic macular oedema: the DIAMONDS non-inferiority RCT.
Lois N; Campbell C; Waugh N; Azuara-Blanco A; Maredza M; Mistry H; McAuley D; Acharya N; Aslam TM; Bailey C; Chong V; Downey L; Eleftheriadis H; Fatum S; George S; Ghanchi F; Groppe M; Hamilton R; Menon G; Saad A; Sivaprasad S; Shiew M; Steel DH; Talks JS; Doherty P; McDowell C; Clarke M
Health Technol Assess; 2022 Dec; 26(50):1-86. PubMed ID: 36541393
[TBL] [Abstract][Full Text] [Related]
34. Anti-vascular endothelial growth factor for neovascular glaucoma.
Simha A; Aziz K; Braganza A; Abraham L; Samuel P; Lindsley KB
Cochrane Database Syst Rev; 2020 Feb; 2(2):CD007920. PubMed ID: 32027392
[TBL] [Abstract][Full Text] [Related]
35. Visual cycle modulators versus placebo or observation for the prevention and treatment of geographic atrophy due to age-related macular degeneration.
Yeong JL; Loveman E; Colquitt JL; Royle P; Waugh N; Lois N
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013154. PubMed ID: 33331670
[TBL] [Abstract][Full Text] [Related]
36. Aqueous shunts for glaucoma.
Tseng VL; Coleman AL; Chang MY; Caprioli J
Cochrane Database Syst Rev; 2017 Jul; 7(7):CD004918. PubMed ID: 28750481
[TBL] [Abstract][Full Text] [Related]
37. Intravitreal ranibizumab versus aflibercept versus bevacizumab for macular oedema due to central retinal vein occlusion: the LEAVO non-inferiority three-arm RCT.
Hykin P; Prevost AT; Sivaprasad S; Vasconcelos JC; Murphy C; Kelly J; Ramu J; Alshreef A; Flight L; Pennington R; Hounsome B; Lever E; Metry A; Poku E; Yang Y; Harding SP; Lotery A; Chakravarthy U; Brazier J
Health Technol Assess; 2021 Jun; 25(38):1-196. PubMed ID: 34132192
[TBL] [Abstract][Full Text] [Related]
38. Corticosteroid implants for chronic non-infectious uveitis.
Reddy A; Liu SH; Brady CJ; Sieving PC; Palestine AG
Cochrane Database Syst Rev; 2023 Jan; 1(1):CD010469. PubMed ID: 36645716
[TBL] [Abstract][Full Text] [Related]
39. Interventions for central serous chorioretinopathy: a network meta-analysis.
Salehi M; Wenick AS; Law HA; Evans JR; Gehlbach P
Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD011841. PubMed ID: 26691378
[TBL] [Abstract][Full Text] [Related]
40. Intravitreal Steroids Compared with Anti-VEGF Treatment for Diabetic Macular Edema: A Meta-Analysis.
Patil NS; Mihalache A; Hatamnejad A; Popovic MM; Kertes PJ; Muni RH
Ophthalmol Retina; 2023 Apr; 7(4):289-299. PubMed ID: 36272716
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
